nach oben

Cardiovascular Drugs and Therapy

Erschienen in:

30.09.2017 | EDITORIAL

Find and Plug the Leak: Improving Adherence to Anti-Hypertensive Medicines

Editorial to: “Assessing Adherence to Antihypertensive Therapy in Primary Health Care in Namibia: Findings and Implications” by M.M. Nashilongo et al.

verfasst von: Benson Njuguna, Rajesh Vedanthan

Erschienen in: Cardiovascular Drugs and Therapy | Ausgabe 5-6/2017

Einloggen, um Zugang zu erhalten

Excerpt

Elevated blood pressure is the leading preventable cause of cardiovascular disease (CVD) death and disability globally [1, 2]. Adherence to anti-hypertensive medicines is the cornerstone to blood pressure control and subsequent reductions in CVD related death and disability [3]. However, adherence to anti-hypertensive medicines remains suboptimal globally and in sub-Saharan Africa (SSA). A recent systematic review estimated rates of non-adherence to be 45% globally, rising to 63% among African and Asian populations [4]. Furthermore, non-adherence was noted in 84% of patients with uncontrolled hypertension. Hypertension prevalence is highest in Africa (46%) compared to other regions and is expected to increase by more than 65% by 2025 [5, 6]. Consequently, there is an urgent need to implement strategies to monitor and improve adherence to anti-hypertensive medicines in SSA. …

GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet (Lond Engl). 2016;388:1659–724.

Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380:2224–60.

Bundy JD, Li C, Stuchlik P, et al. Systolic blood pressure reduction and risk of cardiovascular disease and mortality: a systematic review and network meta-analysis. JAMA Cardiol. 2017;2(7):775–81.CrossRefPubMed

Abegaz TM, Shehab A, Gebreyohannes EA, Bhagavathula AS, Elnour AA. Nonadherence to antihypertensive drugs: a systematic review and meta-analysis. Medicine. 2017;96(4):e5641.CrossRefPubMedPubMedCentral

Cappuccio FP, Miller MA. Cardiovascular disease and hypertension in sub-Saharan Africa: burden, risk and interventions. Intern Emerg Med. 2016;11:299–305.CrossRefPubMedPubMedCentral

Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217–23.

Stuckler D, Basu S, McKee M. Drivers of inequality in millennium development goal progress: a statistical analysis. PLoS Med. 2010;7(3):e1000241.CrossRefPubMedPubMedCentral

Khatib R, Schwalm J-D, Yusuf S, Haynes RB, McKee M, Khan M, et al. Patient and healthcare provider barriers to hypertension awareness, treatment and follow up: a systematic review and meta-analysis of qualitative and quantitative studies. PLoS One. 2014;9(1):e84238.CrossRefPubMedPubMedCentral

Nashilongo MM, Singu B, Kalemeera F, et al. Assessing adherence to antihypertensive therapy in primary health care in Namibia: findings and implications. Cardiovasc Drugs Ther 2017;31: this issue.

10.

Lulebo AM, Mutombo PB, Mapatano MA, Mafuta EM, Kayembe PK, Ntumba LT, et al. Predictors of non-adherence to antihypertensive medication in Kinshasa, Democratic Republic of Congo: a cross-sectional study. BMC Res Notes. 2015;8:526.CrossRefPubMedPubMedCentral

11.

Ambaw AD, Alemie GA, WY SM, Mengesha ZB. Adherence to antihypertensive treatment and associated factors among patients on follow up at University of Gondar Hospital, Northwest Ethiopia. BMC Public Health. 2012;12:282.CrossRefPubMedPubMedCentral

12.

Ghembaza MA, Senoussaoui Y, Tani MK, Meguenni K. Impact of patient knowledge of hypertension complications on adherence to antihypertensive therapy. Curr Hypertens Rev. 2014;10(1):41–8.CrossRefPubMed

13.

Mugomeri E, Ramathebane MV, Maja L, Chatanga P, Moletsane L. Knowledge of disease condition and medications among hypertension patients in Lesotho. J Am Soc Hypertens. 2016;10(1):41–6.CrossRefPubMed

14.

Goverwa TP, Masuka N, Tshimanga M, Gombe NT, Takundwa L, Bangure D, et al. Uncontrolled hypertension among hypertensive patients on treatment in Lupane District, Zimbabwe, 2012. BMC Res Notes. 2014;7:703.CrossRefPubMedPubMedCentral

15.

Gold DT, McClung B. Approaches to patient education: emphasizing the long-term value of compliance and persistence. Am J Med. 2006;119(4):S32–S7.CrossRefPubMed

16.

Adeyemo A, Tayo BO, Luke A, Ogedegbe O, Durazo-Arvizu R, Cooper RS. The Nigerian anti-hypertensive adherence trial (NA-HAT): a community-based randomized trial. J Hypertens. 2013;31(1):201–7.CrossRefPubMedPubMedCentral

17.

World Health Organization. Equitable access to essential medicines: a framework for collective action. WHO policy perspectives on medicines no. 8. Geneva: WHO; 2004.

18.

Maginga J, Guerrero M, Koh E, Hansen CH, Shedafa R, Kalokola F, et al. Hypertension control and its correlates among adults attending a hypertension clinic in Tanzania. J Clin Hypertens (Greenwich). 2016;18(3):207–16.CrossRef

19.

Mugwano I, Kaddumukasa M, Mugenyi L, Kayima J, Ddumba E, Sajatovic M, et al. Poor drug adherence and lack of awareness of hypertension among hypertensive stroke patients in Kampala, Uganda: a cross sectional study. BMC Res Notes. 2016;9:3.CrossRefPubMedPubMedCentral

20.

Pastakia SD, Manyara SM, Vedanthan R, Kamano JH, Menya D, Andama B, et al. Impact of bridging income generation with group integrated care (BIGPIC) on hypertension and diabetes in rural western Kenya. J Gen Intern Med. 2017;32(5):540–8.CrossRefPubMed

21.

Vedanthan R, Kamano JH, Lee H, Andama B, Bloomfield GS, DeLong AK, et al. Bridging income generation with group integrated care for cardiovascular risk reduction: rationale and design of the BIGPIC study. Am Heart J. 2017;188:175–85.CrossRefPubMed

22.

Vedanthan R, Kamano JH, Bloomfield GS, Manji I, Pastakia S, Kimaiyo SN. Engaging the entire care Cascade in western Kenya: a model to achieve the cardiovascular disease secondary prevention roadmap goals. Glob Heart. 2015;10(4):313–7.CrossRefPubMedPubMedCentral

23.

Khabala KB, Edwards JK, Baruani B, Sirengo M, Musembi P, Kosgei RJ, et al. Medication adherence clubs: a potential solution to managing large numbers of stable patients with multiple chronic diseases in informal settlements. Tropical Med Int Health. 2015;20(10):1265–70.CrossRef

24.

Ford N, Nachega JB, Engel ME, Mills EJ. Directly observed antiretroviral therapy: a systematic review and meta-analysis of randomised clinical trials. Lancet. 2009;374:2064–71.

25.

Tran DN, Njuguna B, Mercer T, Manji I, Fischer L, Lieberman M, et al. Ensuring patient-centered access to cardiovascular disease medicines in low-income and middle-income countries through health-system strengthening. Cardiol Clin. 2017;35(1):125–34.CrossRefPubMed

Titel: Find and Plug the Leak: Improving Adherence to Anti-Hypertensive Medicines
Editorial to: “Assessing Adherence to Antihypertensive Therapy in Primary Health Care in Namibia: Findings and Implications” by M.M. Nashilongo et al.
verfasst von: Benson Njuguna
Rajesh Vedanthan
Publikationsdatum: 30.09.2017
Verlag: Springer US
Erschienen in: Cardiovascular Drugs and Therapy / Ausgabe 5-6/2017
Print ISSN: 0920-3206
Elektronische ISSN: 1573-7241
DOI: https://doi.org/10.1007/s10557-017-6753-y

Neu im Fachgebiet Kardiologie

25.04.2024 | Hypotonie | Nachrichten

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Find and Plug the Leak: Improving Adherence to Anti-Hypertensive Medicines

Editorial to: “Assessing Adherence to Antihypertensive Therapy in Primary Health Care in Namibia: Findings and Implications” by M.M. Nashilongo et al.

Excerpt

Neu im Fachgebiet Kardiologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adipositas-Medikament auch gegen Schlafapnoe wirksam

Komplette Revaskularisation bei Infarkt: Neue Studie setzt ein Fragezeichen

Update Kardiologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5-6/2017

Prevalence of Prediabetes and Undiagnosed Diabetes in Patients with HFpEF and HFrEF and Associated Clinical Outcomes

Barriers to Beta-Blocker Use and Up-Titration Among Patients with Heart Failure with Reduced Ejection Fraction

The Impact of Vascular Disease Treatment on Platelet-Derived Microvesicles

Novel Synthesized Radical-Containing Nanoparticles Limit Infarct Size Following Ischemia and Reperfusion in Canine Hearts

Rationale and Design of Low-dose Administration of Carperitide for Acute Heart Failure (LASCAR-AHF)

Assessing Adherence to Antihypertensive Therapy in Primary Health Care in Namibia: Findings and Implications

Neu im Fachgebiet Kardiologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adipositas-Medikament auch gegen Schlafapnoe wirksam

Komplette Revaskularisation bei Infarkt: Neue Studie setzt ein Fragezeichen

Update Kardiologie